Comments
Shares of Krebs Biochemicals & Industries will turn ex-rights on Thursday. The company plans to raise ₹25 crore through the rights issue from existing shareholders by offering 21 shares for every 100 held at ₹75 share.
Investors wishing to participate in the rights issue need to own the company’s shares by Wednesday, as the record date has been set as February 1. The stock of Krebs Biochemicals, which on Tuesday closed at ₹113.95 on the BSE, will remain in focus.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.